nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
2016 annual congress of the European Respiratory Society
|
Akkermans, Rebecca |
|
2016 |
4 |
10 |
p. 773- 1 p. |
artikel |
2 |
Citizens' juries: the public verdict on antibiotic resistance
|
Burki, Talha |
|
2016 |
4 |
10 |
p. 779- 1 p. |
artikel |
3 |
COPD case finding: effective, but also cost-effective?
|
van Boven, Job FM |
|
2016 |
4 |
10 |
p. e49- 1 p. |
artikel |
4 |
COPD case finding: effective, but also cost-effective? – Authors' reply
|
Jordan, Rachel E |
|
2016 |
4 |
10 |
p. e50- 1 p. |
artikel |
5 |
Corrections
|
|
|
2016 |
4 |
10 |
p. e50- 1 p. |
artikel |
6 |
Corrections
|
|
|
2016 |
4 |
10 |
p. e50- 1 p. |
artikel |
7 |
Does barnyard dust protect Amish children from asthma?
|
Furlow, Bryant |
|
2016 |
4 |
10 |
p. 774- 1 p. |
artikel |
8 |
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
|
O'Byrne, Paul M |
|
2016 |
4 |
10 |
p. 797-806 10 p. |
artikel |
9 |
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
|
Hanania, Nicola A |
|
2016 |
4 |
10 |
p. 781-796 16 p. |
artikel |
10 |
Extremis: a sensitive look at life (and death) in the ICU
|
Burki, Talha |
|
2016 |
4 |
10 |
p. 780- 1 p. |
artikel |
11 |
FDA approves first generic version of Tamiflu
|
Lobo, Patricia |
|
2016 |
4 |
10 |
p. 775- 1 p. |
artikel |
12 |
Focusing on breath
|
Wilton, Jayne |
|
2016 |
4 |
10 |
p. 780- 1 p. |
artikel |
13 |
Focus on latent tuberculosis
|
The Lancet Respiratory Medicine, |
|
2016 |
4 |
10 |
p. 763- 1 p. |
artikel |
14 |
Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST
|
Taylor, Colman |
|
2016 |
4 |
10 |
p. 818-825 8 p. |
artikel |
15 |
Lessons from LAVOLTA
|
Pavord, Ian D |
|
2016 |
4 |
10 |
p. 764-765 2 p. |
artikel |
16 |
Mild obstructive sleep apnoea: clinical relevance and approaches to management
|
McNicholas, Walter T |
|
2016 |
4 |
10 |
p. 826-834 9 p. |
artikel |
17 |
Neutrophilic asthma: a distinct target for treatment?
|
Chung, Kian Fan |
|
2016 |
4 |
10 |
p. 765-767 3 p. |
artikel |
18 |
Paracetamol no worse than ibuprofen in children with mild asthma
|
Venkatesan, Priya |
|
2016 |
4 |
10 |
p. 775- 1 p. |
artikel |
19 |
Rapid changes in the respiratory environment in Albania
|
Dumiak, Michael |
|
2016 |
4 |
10 |
p. 776-777 2 p. |
artikel |
20 |
Sedation quality in intensive care: which interventions work?
|
Riker, Richard R |
|
2016 |
4 |
10 |
p. 767-768 2 p. |
artikel |
21 |
Staff education, regular sedation and analgesia quality feedback, and a sedation monitoring technology for improving sedation and analgesia quality for critically ill, mechanically ventilated patients: a cluster randomised trial
|
Walsh, Timothy S |
|
2016 |
4 |
10 |
p. 807-817 11 p. |
artikel |
22 |
The challenge of reducing smoking in people with serious mental illness
|
Sharma, Ratika |
|
2016 |
4 |
10 |
p. 835-844 10 p. |
artikel |
23 |
The cost of shock resuscitation treatment decisions
|
Pinsky, Michael R |
|
2016 |
4 |
10 |
p. 769-770 2 p. |
artikel |
24 |
Unconventional natural gas development and respiratory health
|
Furlow, Bryant |
|
2016 |
4 |
10 |
p. 778- 1 p. |
artikel |
25 |
Usual interstitial pneumonia pattern in the diagnosis of idiopathic pulmonary fibrosis?
|
Tzilas, Vasilios |
|
2016 |
4 |
10 |
p. 770-772 3 p. |
artikel |